Germany · 
Who invested in FundaMental Pharma?
FundaMental Pharma's investors include Novartis.
Germany · Seed startup
Who invested in FundaMental Pharma
Funding summaryUpdated 26 Oct 2026
$2.9Mraised across 1 round since 2024, from 1 source
- Latest round
- Seed, $2.9MApr 2024
- Investors
- 1
The rounds
- Apr 2024
Founders and team
From FundaMental Pharma's own website: 14 on the team.
- Dirk BeherCEO
- Hans ErikssonChief Medical Officer
- Alexander StraubHead of Chemistry
- Colin KahrsHead of Intellectual Property
- Igor VelichkovHead of Finance
- Manfred SchneiderHead of DMPK & Toxicology
- Rolf PokornyHead of Clinical Development
- Tara DavisHead of Structural Biology
- Gordon HaltenhofTechnician & Laboratory Manager
- Jing YanDirector Research
- Keno GutierrezChairman of the Board
- Manuela SimonettiPrincipal Scientist
- Michael AlbersDirector Preclinical Development
- Vera Mehler-de GraaffNon-Executive Director
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about FundaMental Pharma
How much has FundaMental Pharma raised?
FundaMental Pharma has raised $2.9M across 1 round since 2024.
When did FundaMental Pharma last raise?
FundaMental Pharma's most recent round was a Seed of $2.9M in Apr 2024.
What was FundaMental Pharma's biggest round?
Its most recent round, $2.9M in Apr 2024, is also its largest on record.
Who backed FundaMental Pharma first?
FundaMental Pharma's first round on record, in Apr 2024, was backed by Novartis.
What stage is FundaMental Pharma at?
FundaMental Pharma's latest named round is a Seed, in Apr 2024.
Where is FundaMental Pharma based?
FundaMental Pharma is based in Germany.
Companies like FundaMental Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.